EXHIBIT 5


                        OLLE, MACAULAY & ZORRILLA, P.A.
                               1402 MIAMI CENTER
                          201 SOUTH BISCAYNE BOULEVARD
                              MIAMI, FLORIDA 33131
                                 (305) 358-9200
                               FAX (305) 358-9617


                                August 29, 1997



ProxyMed, Inc.
2501 Davie Road
Suite 230
Ft. Lauderdale, FL  33317

         RE:  REGISTRATION STATEMENT ON FORM S-8

Gentlemen:

         We have acted as counsel to ProxyMed, Inc., a Florida corporation (the
"Company"), in connection with the preparation and filing of the Registration
Statement on Form S-8 (the "Registration Statement") filed with the Securities
and Exchange Commission (the "Commission") under the Securities Act of 1933, as
amended (the "Securities Act"), relating to 60,000 shares of the Company's
Common Stock, $.001 par value per share (the "Common Stock"), that are offered
pursuant to an employee Stock Option Agreement dated as of November 11, 1996, as
amended as of August 29, 1997, between the Company and Jeffrey Backerman (the
"Agreement"). You have requested the opinion of this firm with respect to
certain legal aspects of the proposed offering of Common Stock pursuant to the
Agreement.

         We have examined original, photostatic or certified copies of such
records of the Company, including the Articles of Incorporation, the Bylaws and
minutes, the Registration Statement and other documents as we have deemed
relevant and necessary for purposes of the opinions hereinafter set forth. In
such examination, we have assumed the genuineness of all signatures, the
authenticity of all documents and instruments submitted to us as originals and
the conformity to authentic originals of all documents and instruments submitted
to us as certified or photostatic copies. As to various questions of fact
material to our opinions, we have relied upon representations made to us by
various officers and directors of the Company and we have not conducted or
received independent verification of those facts.

         Based upon the foregoing and subject to the comments and exceptions
noted below, we are of the opinion that the Company

                                       9





ProxyMed, Inc.
August 29, 1997
Page 10

presently has available at least 60,000 authorized but unissued shares and/or
treasury shares of Common Stock from which may be issued the 60,000 shares of
Common Stock proposed to be sold pursuant to the Agreement. Assuming that the
Company maintains an adequate number of authorized but unissued shares and/or
treasury shares of Common Stock available for issuance to Mr. Backerman as set
forth in the Agreement and assuming that the consideration for the shares of
Common Stock issued is actually received by the Company as provided in the
Agreement, then the shares of Common Stock issued pursuant to the Agreement will
be legally and validly issued, fully paid and nonassessable.

         We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement. In giving such consent, we do not admit that we come
within the category of persons whose consent is required by Section 7 of the
Securities Act or the rules and regulations of the Commission thereunder.

                                               Very truly yours,

                                               OLLE, MACAULAY & ZORRILLA, P.A.